We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+17.61%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
+$1.44B
Cap. Flow
+$92.7M
Cap. Flow %
0.88%
Top 10 Hldgs %
22.72%
Holding
2,357
New
64
Increased
127
Reduced
1,296
Closed
88

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$395M
2
TSLA icon
Tesla
TSLA
+$94.3M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23M
4
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
+$4.29M
5
PRG icon
PROG Holdings
PRG
+$3.34M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$23.3M
2
MSFT icon
Microsoft
MSFT
+$17.8M
3
AMZN icon
Amazon
AMZN
+$13.9M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$10.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$8.35M

Sector Composition

Rank Sector Weight
1 Technology 20.97%
2 Healthcare 12.78%
3 Financials 12.6%
4 Consumer Discretionary 11.75%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CATC
2026
DELISTED
CAMBRIDGE BANCORP
CATC
$185K ﹤0.01%
2,648
– –
KE
2027
Kimball Electronics
KE
$606M
$183K ﹤0.01%
11,468
– –
SPRO icon
2028
Spero Therapeutics
SPRO
$68.9M
$183K ﹤0.01%
+9,430
New +$147K
FCBC icon
2029
First Community Bankshares
FCBC
$927M
$183K ﹤0.01%
8,470
– –
CDMO
2030
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$182K ﹤0.01%
15,803
-3,700
-19% -$33.8K
CLVS
2031
DELISTED
Clovis Oncology, Inc.
CLVS
$181K ﹤0.01%
37,631
+3,655
+11% +$18.5K
URGN icon
2032
UroGen Pharma
URGN
$2.39B
$180K ﹤0.01%
9,990
– –
QTTB icon
2033
Q32 Bio
QTTB
$458M
$180K ﹤0.01%
884
– –
TRST
2034
Trustco Bank Corp NY
TRST
$963M
$180K ﹤0.01%
5,387
-15
-0.3% -$452
CRNX icon
2035
Crinetics Pharmaceuticals
CRNX
$8.96B
$180K ﹤0.01%
12,732
– –
MSBI icon
2036
Midland States Bancorp
MSBI
$696M
$179K ﹤0.01%
10,034
– –
IMXI icon
2037
International Money Express
IMXI
$343M
$178K ﹤0.01%
11,455
– –
DTIL icon
2038
Precision BioSciences
DTIL
$205M
$178K ﹤0.01%
710
-197
-22% -$48.3K
CCCC icon
2039
C4 Therapeutics
CCCC
$480M
$177K ﹤0.01%
+5,348
New +$155K
HVT icon
2040
Haverty Furniture Companies
HVT
$441M
$177K ﹤0.01%
6,403
– –
FLIC
2041
DELISTED
First of Long Island Corp
FLIC
$177K ﹤0.01%
9,924
– –
FOSL icon
2042
Fossil Group
FOSL
$311M
$177K ﹤0.01%
20,424
-902
-4% -$7.58K
PLYM
2043
DELISTED
Plymouth Industrial REIT
PLYM
$177K ﹤0.01%
+11,804
New +$158K
CIVI
2044
DELISTED
Civitas Resources
CIVI
$177K ﹤0.01%
9,142
– –
ALNT icon
2045
Allient
ALNT
$1.94B
$176K ﹤0.01%
5,181
– –
CNR
2046
DELISTED
Cornerstone Building Brands, Inc.
CNR
$176K ﹤0.01%
18,929
-657
-3% -$5.83K
RYAM icon
2047
Rayonier Advanced Materials
RYAM
$561M
$176K ﹤0.01%
26,919
-880
-3% -$4.67K
JYNT icon
2048
The Joint Corp
JYNT
$123M
$175K ﹤0.01%
6,678
– –
MNRL
2049
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$175K ﹤0.01%
15,907
– –
EAR
2050
DELISTED
Eargo, Inc. Common Stock
EAR
$175K ﹤0.01%
+195
New +$164K
80 81
82
83 84

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

MetLife Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, MetLife Investment Management held 2,357 positions worth $10.6B, up 16% from $9.13B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

MetLife Investment Management's Q4 2020 filing shows 64 new, 127 increased, 1,296 reduced and 88 closed positions. Its largest new stake was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M. The largest sale was Apple, an estimated $23.3M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2020 buy was Vanguard Short-Term Bond ETF: 4,766,514 shares worth $395M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $23M increase.
  • MetLife Investment Management's biggest Q4 2020 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Dunkin' Brands Group, Inc. in Q4 2020, selling an estimated $3.86M.
  • MetLife Investment Management's ten largest holdings make up 23% of its $10.6B portfolio in Q4 2020.
  • MetLife Investment Management opened 64 new positions and closed 88 in Q4 2020.
  • MetLife Investment Management's portfolio value rose 16% quarter-over-quarter to $10.6B.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.